SITC Sets Nov. 4 Briefing on Eight Cancer Immunotherapy Abstracts
Image
MILWAUKEE – October 29, 2026 -- The Society for Immunotherapy of Cancer (SITC) received almost 1,200 abstract submissions for 2026 and will showcase eight selected studies at a virtual press briefing on Wednesday, Nov. 4, from 12 to 1:30 p.m. MT.
SITC publishes accepted late-breaking abstracts ahead of its 41st Annual Meeting
The society has released titles and authors for the accepted Late-breaking Abstracts, which contain new data from interventional clinical trials in humans. They will be presented at the 41st Annual Meeting & Pre-Conference Programs, held Nov. 4-8, 2026, in Phoenix, AZ, and virtually.
Briefing lineup spans cell therapies, oncolytic viruses and a PD-1/VEGF bispecific
Eight presentations are scheduled, in this order: